Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03848845
Brief Title: Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 4)

First Submitted : February 19, 2019
First Submitted that Met QC Criteria : February 19, 2019
First Posted : February 21, 2019

Last Update Submitted that Met QC Criteria : September 30, 2021
Last Update Posted : October 1, 2021